Eva Kalias has worked with Weber-Thedy since 2004. She leads strategic projects in financial and corporate communication as well as investor and capital market relations. She focuses on the pharmaceutical, biotechnology, medical technology and chemical industries and on private equity.
Eva previously managed and marketed private equity investments in pharma and biotech on behalf of Swiss Life. Prior to that, she headed global investor relations teams at Alusuisse Lonza Group, Ciba Specialty Chemicals and Ciba-Geigy (now Novartis). Eva started her career as an International Product Manager for pharmaceuticals at Ciba-Geigy.
Eva received a Master’s degree in Biochemistry from the University of Zurich and an MBA from IMD business school in Lausanne, Switzerland.